Mirabella Financial Services LLP Acquires New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Mirabella Financial Services LLP purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 35,222 shares of the company’s stock, valued at approximately $10,569,000. HCA Healthcare accounts for 0.9% of Mirabella Financial Services LLP’s portfolio, making the stock its 24th biggest holding.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $840,286,000. Royal London Asset Management Ltd. boosted its holdings in HCA Healthcare by 62.0% in the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock worth $450,461,000 after acquiring an additional 574,239 shares in the last quarter. Barclays PLC raised its position in shares of HCA Healthcare by 85.7% in the 4th quarter. Barclays PLC now owns 1,061,891 shares of the company’s stock valued at $318,727,000 after purchasing an additional 489,916 shares during the last quarter. Principal Financial Group Inc. grew its position in HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after purchasing an additional 476,756 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of HCA Healthcare in the fourth quarter worth $74,121,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.0 %

Shares of NYSE HCA opened at $334.38 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The business’s 50 day moving average is $328.55 and its two-hundred day moving average is $334.13. The firm has a market cap of $82.32 billion, a price-to-earnings ratio of 15.22, a PEG ratio of 1.10 and a beta of 1.48. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business earned $5.90 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research reports. Barclays lowered their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Bank of America dropped their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. StockNews.com cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, April 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Guggenheim assumed coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating on the stock. One analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $381.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.